Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Ani Pharmaceuticals (ANIP) over the last 17 years, with Q3 2025 value amounting to $709.8 million.

  • Ani Pharmaceuticals' Non-Current Assets fell 735.3% to $709.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 5673.84%. This contributed to the annual value of $756.0 million for FY2024, which is 9656.82% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Non-Current Assets of $709.8 million as of Q3 2025, which was down 735.3% from $740.4 million recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Non-Current Assets high stood at $766.1 million for Q3 2024, and its period low was $279.1 million during Q3 2021.
  • In the last 5 years, Ani Pharmaceuticals' Non-Current Assets had a median value of $415.8 million in 2022 and averaged $476.9 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 1314.24% in 2021, then surged by 10267.87% in 2025.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Non-Current Assets stood at $449.8 million in 2021, then decreased by 7.56% to $415.8 million in 2022, then fell by 7.51% to $384.6 million in 2023, then soared by 96.57% to $756.0 million in 2024, then dropped by 6.12% to $709.8 million in 2025.
  • Its Non-Current Assets stands at $709.8 million for Q3 2025, versus $740.4 million for Q2 2025 and $756.1 million for Q1 2025.